Literature DB >> 198505

Apolipoprotein A-II content of human plasma high density lipoproteins measured by radioimmunoassay.

G Schonfeld, J Chen, W F McDonnell, I Jeng.   

Abstract

A double antibody radioimmunoassay for human ApoA-II is reported. ApoA-II isolated from human plasma high density lipoprotein (HDL) by column chromatography migrated as a single band on polyacrylamide disc gel electrophoresis, had the appropriate amino acid composition, and provoked the production of monospecific antisera. (125)I-ApoA-II (iodinated by lactoperoxidase, purified by Sephadex G-75 chromatography) migrated with "cold" ApoA-II as a single band on disc gel electrophoresis in SDS. Its specific radioactivity was 5-12 mCi/ micro g. In assays, (0.05 M barbital buffer, 0.01% Triton X-100, pH 8.6) over 90% of (125)I-ApoA-II was bound by excess first antibody and over 95% was displaced by excess "cold" ApoA-II. Low density lipoprotein, very low density lipoprotein, ApoA-I, ApoC-II, and ApoC-III displaced no counts. Intraassay and interassay coefficients of variation for lipoprotein or plasma samples were 7 +/- 4 and 11 +/- 6%, respectively. As little as 1.0 ng of ApoA-II was detectable with a precision of 10%. ApoA-II made up 20-25% of the proteins of HDL (d 1.083-1.19), HDL(2) (d 1.083-1.124), and HDL(3) (d 1.124-1.19) on column chromatography. The ApoA-II contents of these HDL fractions were also 20-25% by radioimmunoassay. Similar results were obtained whether assays were carried out on intact or delipidated HDL samples. Thus, in contrast with ApoA-I (only 10% of which is detectable), all of the ApoA-II contents of intact HDL are detected with accuracy by this assay. Plasma levels of ApoA-II in young normolipemic subjects were approximately 40 mg/dl (n = 29). In these subjects, over 98% of ApoA-II was found in the d 1.063-1.21 density fractions.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 198505

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  6 in total

1.  Tangier disease: heterozygote detection and linkage analysis.

Authors:  B K Suarez; G Schonfeld; R S Sparkes
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

2.  Plasma, apolipoprotein, A-I and A-II levels in hyperlipidemia.

Authors:  G Schonfeld; A Bailey; R Steelman
Journal:  Lipids       Date:  1978-12       Impact factor: 1.880

3.  Effects of dietary cholesterol and fatty acids on plasma lipoproteins.

Authors:  G Schonfeld; W Patsch; L L Rudel; C Nelson; M Epstein; R E Olson
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

4.  Structure, immunology, and cell reactivity of low density lipoprotein from umbilical vein of a newborn type II homozygote.

Authors:  W Patsch; J L Witztum; R Ostlund; G Schonfeld
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

5.  Apolipoprotein M expression increases the size of nascent pre beta HDL formed by ATP binding cassette transporter A1.

Authors:  Anny Mulya; Jeongmin Seo; Amanda L Brown; Abraham K Gebre; Elena Boudyguina; Gregory S Shelness; John S Parks
Journal:  J Lipid Res       Date:  2009-09-18       Impact factor: 5.922

6.  Lack of effect of drinking water barium on cardiovascular risk factors.

Authors:  R G Wones; B L Stadler; L A Frohman
Journal:  Environ Health Perspect       Date:  1990-04       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.